Status:
COMPLETED
Clinical and Echocardiographic Management of Patients With Heart Failure and Diabetes: SCODIAC Follow up Study
Lead Sponsor:
Federico II University
Conditions:
Diabetes
Heart Failure
Eligibility:
All Genders
65-90 years
Brief Summary
The study has been carried out to determine diagnostic and therapeutic pathways in a group of HF diabetic patients and to verify whether the use of innovative antidiabetic therapies could modify echoc...
Detailed Description
406 patients affected with heart failure and Type 2 Diabetes Mellitus, referred to Cardiologists and Diabetologists of pertaining healthcare districts in Campania, and followed for at least one year b...
Eligibility Criteria
Inclusion
- age at least 65 years
- presence of chronic HF, defined as a stable clinical syndrome with typical symptoms and signs and echocardiographic evidence of cardiac involvement
- New York Heart Association (NYHA) class II-III
- diagnosis of T2DM from at least 2 years
Exclusion
- cardiac surgery performed during the last year
- age less than 65 years
- significant valvulopathies
- malignant neoplasms
- advanced chronic kidney disease
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
406 Patients enrolled
Trial Details
Trial ID
NCT04375943
Start Date
April 1 2018
End Date
September 1 2019
Last Update
May 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Federico II University
Naples, Italy, 80131